w Latin American Fellows in the Biomedical Sciences are:
Fellow Host Laboratory
Mariano Andres Belluscio, Ph.D., Argentina Rutgers University
Katia Carneiro de Paula, Ph.D., Brazil Forsyth Institute/Harvard
School of Dental Medicine
Mauro Javier Cortez Veliz, Ph.D., Brazil Yale University
Maria de la Paz Fernandez, Ph.D., Argentina Harvard University
Nicolas Frankel, Ph.D., Argentina Princeton University
Paula Licona-Limon, Ph.D., Mexico Yale University
Leticia Irene Llarrull, Ph.D., Argentina University of Notre Dame
Cecilia Martin, Ph.D., Mexico Massachusetts General
Hospital
Hector Alex Saka, Ph.D., Argentina Duke University
Marcos Sawada Simoes-Costa, Ph.D., Brazil California Institute of
Technology
For full biographies and information regarding the fellows' research
subjects, please visit http://www.pewtrusts.org.
The Pew Charitable Trusts (http://www.pewtrusts.org) is driven by the power of
knowledge to solve today's most challenging problems. Pew applies a
rigorous, analytical approach to improve public policy, inform the public
and stimulate civic life. We partner with a diverse range of donors, public
and private organizations and concerned citizens who share our commitment
to fact-based solutions and goal-driven investments to improve society.
'/>"/>SOURCE Pew Charitable Trusts Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related biology technology :1.
Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin2.
Monsantos Industry-Leading Seed Position Creates Accelerated Biotech Trait Opportunity in Latin America3.
Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin4.
Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results5.
Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th6.
White Paper Details New Techniques for Isolating, Identifying Anaerobic Bacteria and Organisms7.
Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial8.
Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Combination REOLYSIN(R) and Carboplatin/Paclitaxel Trial9.
Proteon Therapeutics Receives European Patent Covering New Method of Dilating Arteries and Veins10.
UCT Specialties (Formerly Petrarch) Announces the Release of Their New Product Guides for Silanes, Silicones, Platinum Catalyst and Glass Coatings11.
Palatin Technologies, Inc. Reports Positive Results of a Phase I Clinical Study With PL-3994 for the Treatment of Congestive Heart Failure